Insider · CIK 0002009173
Cecilia Mao
Files at EFX (EQUIFAX INC), CBOE (Cboe Global Markets, Inc.). First filing Feb 19, 2026, latest Feb 19, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EFX: EQUIFAX INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | EQUIFAX INC | $465k 2,400 shares | +29% | +10% from low-31% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | EFX EQUIFAX INC | AGrant or award Common Stock | +2,695 | $0.00 | $0 | 13,318 | Feb 27, 2026 |
| Feb 18, 2026 | EFX EQUIFAX INC | POpen-market purchase Common Stock10b5-1 | +2,400 | $193.72 | $465k | 10,623 | Feb 19, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | AGrant or award Common Stock | +1,374 | $0.00 | $0 | 9,141 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | FTax withholding Common Stock | -918 | $202.71 | $186k | 8,223 | Feb 12, 2026 |
| May 6, 2025 | CBOE Cboe Global Markets, Inc. | AGrant or award Common Stock | +729 | $0.00 | $0 | 1,911 | May 8, 2025 |
| Feb 11, 2025 | EFX EQUIFAX INC | AGrant or award Common Stock | +594 | $0.00 | $0 | 8,095 | Feb 13, 2025 |
| Feb 11, 2025 | EFX EQUIFAX INC | FTax withholding Common Stock | -346 | $253.00 | $88k | 7,749 | Feb 13, 2025 |
| Feb 10, 2025 | EFX EQUIFAX INC | AGrant or award Common Stock | +791 | $0.00 | $0 | 7,501 | Feb 12, 2025 |
| Feb 10, 2025 | EFX EQUIFAX INC | AGrant or award Stock Option/Right to Buyderivative | +2,541 | $0.00 | $0 | 2,541 | Feb 12, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.